Michael Sigouros

Michael Sigouros, B.S. Tufts University, is focusing his research on characterizing AR-negative NEPC as a mechanism of resistance to enzalutamide. He is the lab manager at Beltran lab, which is focused on understanding mechanisms of treatment resistance in advanced prostate cancer through integration of clinical and molecular features of patients combined with preclinical modeling. In addition, as part of the Englander Institute for Precision Medicine and in collaboration with a multidisciplinary team of scientists and clinicians, Beltran Lab is developing genomic and other platforms for biomarker development and clinical application across tumor types.